# Bioequivalence Study of Divalproex Sodium 125 MG Delayed Release Tablets Under Fasting Conditions

> **NCT00864006** · PHASE1 · COMPLETED · sponsor: **Sandoz** · enrollment: 28 (actual)

## Conditions studied

- Seizures

## Interventions

- **DRUG:** Divalproex Sodium
- **DRUG:** Depakote DR Tablets

## Key facts

- **NCT ID:** NCT00864006
- **Lead sponsor:** Sandoz
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2006-10
- **Final completion:** 2006-10
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2017-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00864006

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00864006, "Bioequivalence Study of Divalproex Sodium 125 MG Delayed Release Tablets Under Fasting Conditions". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00864006. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*